150 related articles for article (PubMed ID: 38507114)
1. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
[TBL] [Abstract][Full Text] [Related]
2. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
Wang L; He M; Fu L; Jin Y
Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
[TBL] [Abstract][Full Text] [Related]
3. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
Yin D; Lu X
Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
Zhang YJ; Lu C
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA HCP5 promotes osteosarcoma cell proliferation, invasion, and migration via the miR-29b-3p-LOXL2 axis.
Tan JD; Zhou MF; Yang S; Lin JP
Kaohsiung J Med Sci; 2022 Oct; 38(10):960-970. PubMed ID: 35899856
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
9. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
10. [LncRNA DRAIC regulates the proliferation, apoptosis, migration and invasion of lung adenocarcinoma cells by targeting let-7i-5p].
Liu BL; Cui YS; Tian YP; Zhu YZ; Hong ZQ; Zhang XM; Sun GG
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):471-481. PubMed ID: 37355465
[No Abstract] [Full Text] [Related]
11. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p.
Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q
Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
Chen J; Zhao D; Meng Q
Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
17. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
19. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.
Meng Q; Li Z; Pan J; Sun X
Hum Cell; 2020 Oct; 33(4):1240-1251. PubMed ID: 32749665
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of long non-coding RNA antisense non-coding RNA in the INK4 locus suppresses OVCAR-3 cells proliferation and induction of apoptosis by Wnt/β-catenin.
Sun L; Cui Y; Jiang K; Li J
J Pharm Pharmacol; 2021 Aug; 73(9):1212-1217. PubMed ID: 33772549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
